How to Treat Heart Arrhythmia and Stop Heart Palpitations

Short Answer

Treatment for a heart arrhythmia depends on which arrhythmia you have, why it's happening, and how much risk it carries. "Arrhythmia" can mean a slow rhythm, a fast rhythm, an irregular rhythm, or extra beats — and those problems do not all need the same treatment. Some are brief and harmless; others can reduce blood flow, raise stroke risk, or become life-threatening. That is why the first step is diagnosis, usually with an ECG and sometimes longer rhythm monitoring, rather than trying to "fix" palpitations by feel alone (NHLBI).

The main tools clinicians choose from are: treating the underlying cause and reducing triggers; rate-control or rhythm-control medications; antiarrhythmic drugs; catheter ablation for specific arrhythmias; a pacemaker for certain slow rhythms or conduction problems; an implantable cardioverter-defibrillator (ICD) for people at risk of dangerous ventricular rhythms; and, when the arrhythmia is atrial fibrillation, anticoagulation to lower stroke risk. Which pieces you need — and in what order — is a cardiologist's decision. Do not start, stop, or change any heart or blood-thinning medication on your own (NHLBI).

⚠️ Emergency first: palpitations with fainting or near-fainting, chest pain, severe shortness of breath, confusion, or a racing heartbeat that will not stop are a call-911 situation. Seek emergency care; don't wait to see if it passes (Mayo Clinic).

First principle: the treatment depends on the type and the risk — "arrhythmia" is not one disease

"Arrhythmia" is an umbrella term. It covers premature or extra beats, fast rhythms such as supraventricular tachycardia (SVT) and atrial fibrillation, slow rhythms such as bradycardia, and dangerous ventricular rhythms. The body experience can overlap — fluttering, pounding, racing, skipped beats — but the biology underneath can be very different. A premature beat may feel dramatic because the next beat lands harder after a pause. Ventricular fibrillation, by contrast, can stop the heart from pumping effectively within minutes (NHLBI).

That is why the first job is not simply to "stop palpitations." It is to identify the rhythm and the driver. Your clinician may ask what the sensation feels like, when it happens, what you were doing, which medicines or stimulants you use, and whether symptoms come with faintness, chest pain, breathlessness, or a history of heart disease. Then they match that story to an ECG, Holter monitor, patch monitor, event monitor, or other testing (NHLBI).

The modern atrial fibrillation guideline approach makes the same "whole picture" logic explicit: treatment is not one drug or one procedure. It includes stroke prevention, symptom control, rhythm or rate decisions, and management of risk factors such as blood pressure, weight, sleep apnea, alcohol, and other cardiovascular conditions (2023 ACC/AHA/ACCP/HRS guideline, *Circulation*). One consensus review frames current AFib care as "multi-domain therapy combining stroke prevention, rhythm control, and therapy of concomitant cardiovascular conditions" (*Europace*, 2025, DOI 10.1093/europace/euaf318).

The practical point: two people can both say "my heart is racing" and leave the cardiology visit with completely different plans. One may need reassurance and trigger work. Another may need medication. Another may be a candidate for ablation. Another may need urgent care.

Start by treating the cause and removing triggers — this is where "how to stop palpitations" usually lands

For many people — especially people with occasional palpitations and no known structural heart disease — the most useful "treatment" starts with finding the trigger. Your heart's electrical system is sensitive to the rest of your body. Fever raises demand. Dehydration lowers circulating volume. Thyroid hormone can push the heart faster. Low blood sugar, alcohol, nicotine, stimulant drugs, some cold medicines, too much caffeine for your body, and stress can all make the heartbeat feel louder, faster, or more irregular. Hormonal shifts around menstruation, pregnancy, or menopause can make palpitations more noticeable too (NHLBI).

So if you're searching for how to stop heart palpitations after eating, from alcohol, from coffee, from sugar, when fasting, at night, in the morning, from lack of sleep, during your period, or hormonally, think "pattern," not instant cure. What changed in the hours before the episode? A large meal? Alcohol the night before? Little sleep? Dehydration? Anxiety? A new medication, including a decongestant or steroid? A hard workout? Too much caffeine? Write it down, because patterns are useful to your clinician.

Self-care is reasonable when palpitations are brief, familiar, and not paired with red-flag symptoms: hydrate, eat regularly if fasting triggers you, reduce alcohol, avoid nicotine and stimulant drugs, be cautious with stimulant cold medicines, sleep enough, and use calming breathing or grounding if anxiety is part of the loop. Cleveland Clinic notes that palpitations often go away without medical treatment when they are caused by things you eat, drink, or do; Mayo Clinic similarly lists stress, stimulants, fever, thyroid hormone changes, and hormonal changes as common causes (Cleveland Clinic).

Alcohol deserves its own sentence because the atrial fibrillation evidence is stronger than "maybe it's a trigger." In a randomized trial of regular drinkers with atrial fibrillation, abstinence reduced AF recurrence and AF burden over 6 months; the 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline says people with AF pursuing rhythm control should minimize or eliminate alcohol to reduce recurrence and burden (Voskoboinik et al., *NEJM* 2020, PubMed 31893513).

Sleep-disordered breathing is another treatable driver, though the evidence needs honest framing. In a meta-analysis of obstructive sleep apnea and sudden cardiac death, the pooled odds ratio for sudden cardiac death in OSA patients was 1.41 (95% CI 0.91–2.16; p = 0.12), with high heterogeneity — an association that was not statistically significant overall. The same paper found a signal when untreated OSA was separated from treated OSA: increased risk in untreated OSA (OR 3.87; 95% CI 1.09–13.81; p = 0.04), but not in those receiving CPAP. Keep both facts together: the overall result was not a clean "OSA causes sudden death" claim, but untreated OSA may be part of a higher-risk cardiovascular pattern, and treating sleep apnea can matter for the heart (OSA and sudden cardiac death meta-analysis, *BMC Cardiovascular Disorders* 2025, PMC12542175).

Vagal maneuvers and "how to stop palpitations immediately" — narrow, supervised, not universal

For certain fast rhythms — especially some forms of SVT — a clinician may teach vagal maneuvers, such as a Valsalva-type strain or a modified Valsalva. These maneuvers use the vagus nerve to slow electrical conduction through the AV node, which can sometimes interrupt a specific kind of rapid rhythm (American Heart Association CPR & ECC guidelines).

But this matters: vagal maneuvers are not a universal "stop any palpitation now" trick. They are for specific, usually narrow-complex tachycardias, and they should be taught in the context of a diagnosis. A rhythm that feels fast could be SVT, atrial fibrillation, sinus tachycardia from dehydration or fever, a medication effect, or something more dangerous. The move that is reasonable for a stable, diagnosed SVT episode is not a substitute for evaluation when the rhythm is new, severe, or paired with red flags. Cleveland Clinic notes that people with chest pain, low blood pressure, shortness of breath, or poor perfusion need urgent care rather than self-treatment (Cleveland Clinic: Vagal Maneuvers).

⚠️ If a racing heart comes with chest pain, fainting, severe breathlessness, confusion, or signs of shock, call 911 and seek emergency care. Do not try a maneuver and wait (American Heart Association CPR & ECC guidelines).

Medications: rate control, rhythm control, and antiarrhythmics

Medications for arrhythmia fall into a few broad jobs. The choice — and any dose — depends on the rhythm, the heart's structure, other conditions such as heart failure or coronary disease, kidney and liver function, drug interactions, and how your body responds. This is a cardiologist's decision, not a self-serve one, and this article describes drug classes and purpose only, not doses.

• Rate-control medicines slow how fast the ventricles beat during fast rhythms such as atrial fibrillation. In AF, the 2023 ACC/AHA/ACCP/HRS guideline recommends beta-blockers or non-dihydropyridine calcium channel blockers for long-term rate control, with the specific agent chosen according to the person's underlying heart substrate and other conditions (management review, PMC11095842).

• Rhythm-control and antiarrhythmic medicines aim to restore or maintain a normal rhythm rather than only slowing the rate. They can help the right person, but they can also create new rhythm problems or interact with other medications, so they are specialist decisions (NHLBI).

• Cause-directed medicines treat what is driving the arrhythmia — for example, thyroid disease, blood pressure, infection, or another condition that is putting electrical stress on the heart (NHLBI).

That antiarrhythmic drugs are a real strategy — but one weighed against procedures — shows up in high-risk populations too. In the MANTRA-VT trial, researchers compared early catheter ablation with antiarrhythmic drug therapy for ventricular tachyarrhythmias in post-heart-attack patients who had ICDs: the rate of appropriate ICD shocks was 7% in the ablation group and 30% in the antiarrhythmic-drug group (P = 0.026), and 82% of the ablation group versus 63% of the drug group had no ICD therapies (P = 0.012). That was a narrow, high-risk group of 58 post-MI patients with ICDs and ventricular tachyarrhythmias. It should not be generalized to people with occasional benign palpitations (MANTRA-VT, *Europace* 2025, PMC12527351).

⚠️ Do not adjust heart-rhythm medicines yourself. A drug that slows one rhythm can be unsafe in another setting, and dose changes can worsen bradycardia, blood pressure, or rhythm instability. Any medication and its dose are individualized by a clinician.

Catheter ablation — for specific arrhythmias, by indication

Catheter ablation targets small areas of heart tissue that are creating or sustaining abnormal electrical signals. For atrial fibrillation, the usual core target is pulmonary vein isolation; for SVT or atrial flutter, the target is different. The procedure is done by an electrophysiologist after weighing the rhythm type, symptoms, medication response, heart structure, and procedural risk (American Heart Association: Ablation for Arrhythmias).

Ablation is established for several arrhythmias, including SVT, atrial flutter, atrial fibrillation, and some ventricular tachycardias. It is often most "curative" for certain SVTs and typical atrial flutter; for atrial fibrillation, it may reduce episodes and symptoms, but recurrence remains possible and follow-up matters. The 2023 ACC/AHA/ACCP/HRS guideline describes catheter ablation as an established rhythm-control option for AF and atrial flutter, useful for symptomatic AF when antiarrhythmic drugs have failed, are not tolerated, are contraindicated, or are not preferred — and as first-line therapy in selected symptomatic patients (management review, PMC11104284).

Ablation is not a first step for ordinary, occasional palpitations without a diagnosed arrhythmia. It is also not a guarantee that the rhythm will never return. In a 755-patient study following AF patients after ablation, atrial tachyarrhythmia recurrence over the 2-year follow-up was detected in 25.2% of cases using 2-week Holter monitoring and in 6.7% using 24-hour Holter monitoring — and the authors noted that patients experience few subjective symptoms after ablation, leading to potential underdiagnosis of recurrence. That is why doctors use objective rhythm monitoring after ablation. Feeling better is important, but symptoms alone can miss recurrence (2-week vs 24-h Holter after AF ablation, *Journal of Arrhythmia* 2025, PMC12450608).

Pacemakers and ICDs — devices for specific problems, not for palpitations in general

Two implantable devices show up in arrhythmia care, and they solve different problems.

A pacemaker helps when the heart rate is too slow or the electrical conduction system is not reliably passing signals through the heart. In bradycardia and conduction disease, permanent pacing is used when symptoms are attributable to slow rhythm after reversible causes have been considered; symptomatic sinus node dysfunction and atrioventricular block are common pacing indications (2018 ACC/AHA/HRS Bradycardia Guideline, *Circulation*).

An implantable cardioverter-defibrillator, or ICD, is for people at risk of life-threatening ventricular arrhythmias such as ventricular tachycardia or ventricular fibrillation. It monitors the rhythm and can deliver therapy, including a shock, to restore rhythm when a dangerous fast rhythm occurs. ICDs are used after cardiac arrest and in selected people at high risk of sudden cardiac arrest, such as some people with weakened heart muscle or inherited rhythm conditions (Mayo Clinic: ICDs).

Neither device is a treatment for ordinary palpitations in general. Both are chosen by a cardiologist or electrophysiologist using defined criteria — not by how scary a palpitation feels in the moment.

Anticoagulation in atrial fibrillation — about stroke, not about the rhythm

When the arrhythmia is atrial fibrillation, one major part of treatment is not about how the heart feels. It is about lowering stroke risk. In AF, the upper chambers do not squeeze in a coordinated way, which can allow blood to pool and clot. If a clot travels to the brain, it can cause a stroke (Mayo Clinic: Atrial fibrillation).

Whether someone needs an anticoagulant is a clinician-led risk decision. Guidelines use stroke-risk tools such as CHA₂DS₂-VASc, along with bleeding risk and shared decision-making. The 2023 ACC/AHA/ACCP/HRS AF guideline recommends anticoagulation for patients whose estimated annual thromboembolic risk is high enough, and recommends direct oral anticoagulants over warfarin for most eligible patients without moderate-to-severe rheumatic mitral stenosis or a mechanical heart valve. This is not a prompt to self-score and self-treat; it is how clinicians structure the decision (management review, PMC11104284).

The stakes are real even when AF is newly found during another cardiac event. In a meta-analysis of new-onset atrial fibrillation during acute myocardial infarction, new-onset AF was observed in 2%–21% of patients with acute myocardial infarction, and long-term oral anticoagulant therapy was associated with significantly reduced all-cause mortality (25.3% vs 33.6%; HR 0.75; 95% CI 0.64–0.90; P = 0.001). The authors note that the cohorts largely reflected vitamin K antagonist/warfarin-era practice, with sparse data specific to direct oral anticoagulants in that setting — so this is not a rule that "everyone with AF after a heart attack needs a blood thinner" (OAC in new-onset AF during AMI meta-analysis, *World Journal of Cardiology* 2026, PMC12896994).

⚠️ Anticoagulation is prescribed and stopped only by a doctor. Never start a blood thinner on your own, and never stop one you've been prescribed without medical guidance. Stopping can sharply change stroke risk.

"Can arrhythmia be cured? Can tachycardia be cured?" — manage vs. cure, honestly

Some arrhythmias can be effectively cured. Many SVTs, for example, come from a small electrical short circuit, and ablation can eliminate the pathway causing the rhythm; Cleveland Clinic notes that catheter ablation can have a high cure rate for certain SVT types. Typical atrial flutter is also often highly ablation-responsive (Cleveland Clinic: SVT).

Other arrhythmias are usually managed rather than permanently cured. Atrial fibrillation often reflects a broader atrial and whole-body substrate — age, blood pressure, sleep apnea, alcohol, weight, inflammation, heart structure, and genetics can all matter. Ablation or medications may reduce episodes and symptoms, sometimes dramatically, but AF can recur, and stroke prevention may still be based on risk rather than symptoms (management review, PMC11095842).

So the honest answer to "can tachycardia be cured?" is: sometimes, depending on the exact tachycardia. The honest answer to "how to cure arrhythmia" is even more conditional: first name the rhythm, then treat the cause, symptoms, and risk.

What a heart-rate and wellbeing tracker can and cannot do

Between visits, it can be useful to notice patterns: your resting heart rate, how you feel after poor sleep, whether alcohol or caffeine changes your next-day symptoms, whether stress days look different, or whether a new medication seems to coincide with palpitations. Those notes can make a cardiology appointment more concrete.

But there is a hard boundary. Welltory tracks heart rate and heart rate variability optically (PPG) and records how you feel — it is not an ECG, it does not detect or diagnose any arrhythmia, and it does not replace the Holter, event monitor, or ECG your cardiologist relies on. It cannot rule out a dangerous rhythm, judge stroke risk, or tell you whether a treatment is working. If you feel an episode, if symptoms change, or if your numbers worry you, that belongs in a conversation with your clinician — and if emergency symptoms appear, it belongs with 911.

(No Welltory cohort numbers on this page — there is no self-report arrhythmia flag in our dataset, so this section stays qualitative by design.)

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

We built this article from verified scientific excerpts and guideline-based framing (2023 ACC/AHA/ACCP/HRS, 2024 ESC, NICE NG196, and NHLBI). Medication, procedure, and device descriptions are given at the level of drug class, procedure, and purpose only — no doses, and no self-adjustment instructions — because those decisions are individualized and made by a cardiologist. Where we quote study numbers, we keep the sample sizes, denominators, and statistical caveats attached to the population studied, and we do not generalize narrow high-risk trial results to people with ordinary palpitations. This article is educational and does not provide diagnosis or treatment instructions. Welltory is not a medical device and does not detect or diagnose arrhythmias.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data